<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2026-01-23</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2026-01-23</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>76</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>1</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
METTL14åœ¨Krasè¯±å¯¼çš„é«“å•æ ¸ç»†èƒç™½è¡€ç—…å‘ç”Ÿä¸­è°ƒæ§è‡ªå™¬ï¼Œä»¥åŠEGR1è°ƒæ§CSF1RåŸºå› ç»„ç»“æ„çš„æ–°å‘ç°ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- ç™Œç—‡å‘ç”Ÿä¸è¿›å±•æœºåˆ¶ï¼šæ¶‰åŠm6Aä¿®é¥°ï¼ˆMETTL14ï¼‰ã€ä¿¡å·é€šè·¯ï¼ˆEZH2/E2F1ã€ATF4ï¼‰ã€åŸºå› ç»„è°ƒæ§ï¼ˆEGR1ï¼‰ä»¥åŠlncRNAï¼ˆIGF1R-AS1ï¼‰åœ¨ç™½è¡€ç—…ã€ä¹³è…ºç™Œã€è‚ç™Œã€èƒ¶è´¨æ¯ç»†èƒç˜¤ç­‰ç™Œç—‡ä¸­çš„ä½œç”¨ã€‚<br />
- å…ç–«ç»†èƒåŠŸèƒ½ä¸è°ƒæ§ï¼šç ”ç©¶å…ç–«ç»†èƒï¼ˆæ ‘çªçŠ¶ç»†èƒã€Î³Î´ Tç»†èƒã€CD8+ Tç»†èƒï¼‰åœ¨æŠ—è‚¿ç˜¤å…ç–«ã€ç»„ç»‡ç›‘è§†åŠSARS-CoV-2æ„ŸæŸ“ä¸­çš„ä½œç”¨ï¼Œä»¥åŠçº³ç±³é¢—ç²’å¯¹å…ç–«ç»†èƒåŠŸèƒ½çš„è¯±å¯¼ã€‚<br />
- ä»£è°¢ä¸ç–¾ç—…ï¼šæ¢è®¨çº¿ç²’ä½“ä»£è°¢å¯¹æ ‘çªçŠ¶ç»†èƒåŠŸèƒ½çš„å½±å“ï¼Œä»¥åŠè„‚è‚ªè‚å‘è‚ç™Œè½¬åŒ–çš„æœºåˆ¶ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- å¤šç»„å­¦è”åˆåˆ†æï¼šç»“åˆRNA-seqã€ATAC-seqã€ChIP-seqã€Hi-Cç­‰æŠ€æœ¯ï¼Œæ·±å…¥è§£æåŸºå› è¡¨è¾¾ã€æŸ“è‰²è´¨å¯åŠæ€§ã€è½¬å½•å› å­ç»“åˆåŠåŸºå› ç»„ä¸‰ç»´ç»“æ„ã€‚<br />
- å•ç»†èƒæµ‹åºï¼ˆscRNA-seqï¼‰ï¼šåº”ç”¨äºå…ç–«ç»†èƒã€CAR Tç»†èƒåŠè‚è„ç–¾ç—…ç ”ç©¶ï¼Œæ­ç¤ºç»†èƒå¼‚è´¨æ€§åŠå¾®ç¯å¢ƒè°ƒæ§ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (76æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE298142 m6A ç”²åŸºè½¬ç§»é…¶ METTL14 é€šè¿‡å¤±è°ƒè‡ªå™¬ä¿ƒè¿›è‡´ç™Œ Kras è¯±å¯¼çš„å¹¼å¹´éª¨é«“å•æ ¸ç»†èƒç™½è¡€ç—… [RNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€regex:onco(logy|logist|gene|genic)ã€RNA-seqã€KRAS<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Guangyao Kong ; Peihua ZhangSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe M6A modification plays an important role in the pathogenesis of various myeloid malignancies. However, its specific role in RAS mutant-induced myeloid malignancy is incompletely understood. In this study, we found that m6A methyltransferase METTL14 was highly expressed and associated with a shorter survival in a RAS-mutant myeloid malignancy, juvenile myelomonocytic leukemia (JMML). The knockout of METTL14 was revealed to significantly promote hematopoietic stem/progenitor cells (HSPCs) expansion and suppresses disease progression in a KrasG12D/+ mutant-induced mouse model of JMML. Moreover, knockout of METTL14 reduces hyperproliferation of KrasG12D/+ HSPCs and suppresses oncogenic KrasG12D/+-induced myeloid disease in a cell-autonomous manner. Mechanistically, we revealed that the knockout of METTL14 reduced the autophagy levels of HSPCs by suppressing the transcription and translation of autophagy-related genes, such as Atg5 and Atg9a, through m6A modification. Furthermore, we found that the autophagy inhibition through knockout of ATG5 in Kras mutant mice promoted the expansion of HSPCs and inhibited the progression of leukemia disease, consistent with the phenotypes of knockout of METTL14. Finally, we observed that combined treatment with an m6A inhibitor and a MEK inhibitor synergistically suppressed JMML growth. Collectively, these findings highlight the critical role of METTL14 in JMML tumorigenesis and suggest that m6A RNA modification represents a promising therapeutic target for this disease.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298142" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE311097 å¤–å‘¨SARS-CoV-2æ„ŸæŸ“åå°é¼ è„‘å…ç–«ç»†èƒçš„å•ç»†èƒRNAæµ‹åº</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€sequencingã€single-cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Lu Tan ; Shea Lowery ; Andrew Thurman ; Stanley PerlmanSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusNeurological and neuropsychiatric symptoms are among the most prevalent Post-Acute Sequelae of COVID-19 (PASC), collectively referred to as neuroPASC. Despite growing recognition, the mechanisms driving neuroPASC remain elusive, hindering therapeutic development. Brain immune cells - particularly microglia - have been implicated, yet current knowledge largely derives from post-mortem tissues with variable disease courses and comorbidities and limited spatial coverage. To address this, we established a PASC animal model by infecting C57BL/6 mice with a sublethal dose of mouse-adapted SARS-CoV-2. Infected mice exhibited persistent behavioural alterations and prolonged neuroinflammation in the absence of direct viral neuroinvasion. Single-cell RNA sequencing of brain immune cells collected at 0, 6, 30, and 100 days post-infection (dpi) revealed underlying dynamic, longitudinal immune responses. Microglia, the predominant brain-resident sentinel cells, displayed sustained expansion of subclusters characterized by inflammatory, stress response, and metabolic reprogramming signatures across all time points. Border-associated macrophages upregulated monocyte attractants during acute infection and were partially replaced by infiltrating monocytes. Concurrently, inflammatory monocytes and neutrophils showed maximal brain infiltration and antiviral activity at 6 dpi, potentially triggering long-term microglial activation. Together, these findings provide a high-resolution atlas of brain myeloid immune dynamics during neuroPASC and highlight a central role of microglia in sustaining chronic neuroinflammation, offering insight into potential therapeutic targets.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311097" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE298134 m6Aç”²åŸºè½¬ç§»é…¶METTL14é€šè¿‡è‡ªå™¬å¤±è°ƒä¿ƒè¿›è‡´ç™ŒKrasè¯±å¯¼çš„å¹¼å¹´å‹éª¨é«“å•æ ¸ç»†èƒç™½è¡€ç—…</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šleukemiaã€regex:onco(logy|logist|gene|genic)ã€KRAS<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Guangyao Kong ; Peihua ZhangSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Mus musculusThe M6A modification plays an important role in the pathogenesis of various myeloid malignancies. However, its specific role in RAS mutant-induced myeloid malignancy is incompletely understood. In this study, we found that m6A methyltransferase METTL14 was highly expressed and associated with a shorter survival in a RAS-mutant myeloid malignancy, juvenile myelomonocytic leukemia (JMML). The knockout of METTL14 was revealed to significantly promote hematopoietic stem/progenitor cells (HSPCs) expansion and suppresses disease progression in a KrasG12D/+ mutant-induced mouse model of JMML. Moreover, knockout of METTL14 reduces hyperproliferation of KrasG12D/+ HSPCs and suppresses oncogenic KrasG12D/+-induced myeloid disease in a cell-autonomous manner. Mechanistically, we revealed that the knockout of METTL14 reduced the autophagy levels of HSPCs by suppressing the transcription and translation of autophagy-related genes, such as Atg5 and Atg9a, through m6A modification. Furthermore, we found that the autophagy inhibition through knockout of ATG5 in Kras mutant mice promoted the expansion of HSPCs and inhibited the progression of leukemia disease, consistent with the phenotypes of knockout of METTL14. Finally, we observed that combined treatment with an m6A inhibitor and a MEK inhibitor synergistically suppressed JMML growth. Collectively, these findings highlight the critical role of METTL14 in JMML tumorigenesis and suggest that m6A RNA modification represents a promising therapeutic target for this disease.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298134" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE285346 çº¿ç²’ä½“ä»£è°¢å’Œä¿¡å·ä¼ å¯¼ç›´æ¥è°ƒæ§æ ‘çªçŠ¶ç»†èƒåœ¨æŠ—è‚¿ç˜¤å…ç–«ä¸­çš„åŠŸèƒ½</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€dendritic cellã€metabolism<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by array ; Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusThis SuperSeries is composed of the SubSeries listed below.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285346" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE302362 çº³ç±³é¢—ç²’è¯±å¯¼æŠ—åŸå‘ˆé€’å•æ ¸ç»†èƒæ¥æºçš„æ ‘çªçŠ¶ç»†èƒå¯æŠ‘åˆ¶è½¬ç§»å¹¶ç¼“è§£è½¬ç§»å¾®ç¯å¢ƒä¸­çš„å…ç–«æŠ‘åˆ¶</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmonocyteã€antigenã€regex:immuno(logy|therapy|suppression)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jeffrey A Ma ; Kate V Griffin ; Kathryn Kang ; Agustina Diener ; Ian A Schrack ; Elizabeth J Bealer ; Laila M Rad ; Rebecca S Pereles ; Jacqueline S Jeruss ; Lonnie D SheaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusMyeloid immune cells play a major role in establishing a suitable microenvironment for metastatic tumor cells. Dysregulated myeloid cells suppress antigen-presentation pathways and effector T cell responses at distal organs, and reprogramming these cells may enhance anti-tumor cytotoxicity. Targeting myeloid cells with poly(lactide-co-glycolide) nanoparticles, which possess intrinsic immunomodulatory properties, can promote monocyte maturation to inhibit metastasis. Intravenously delivered nanoparticles made with polyvinyl alcohol, but not other surfactants, reduce the accumulation of neutrophils at the metastatic niche and induce the differentiation of monocytes into antigen-presenting monocyte-derived dendritic cells. The internalization of nanoparticles was linked to the upregulation of gene expression programs in monocyte-derived dendritic cells associated with antigen presentation and T cell stimulation, and ligand-receptor network modeling supports increased activation of Th1 cells by these monocyte-derived dendritic cells. Nanoparticle administration increased the proportion of CD4 cells with Th1 and Th17 phenotypes and did not inhibit metastasis in mice where monocytes or T cells were depleted, indicating that interactions between monocyte-derived dendritic cells and T cells are essential to the mechanism of action. Collectively, our findings demonstrate that nanoparticles can reprogram circulating monocytes into monocyte-derived dendritic cells to modulate the metastatic niche and enhance antigen presentation to stimulate intrinsic T cell responses.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302362" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> <strong>GSE313170 ç ”ç©¶æ¬¡é»„ç´ åŒ–é€”å¾„åœ¨å‰åˆ—è…ºç™Œè¿›å±•ä¸­çš„ä½œç”¨</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€pathway<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Michel Kahi ; Anne Vincent ; JeanJacques Diaz ; Frederic BostSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensWe studied the involvement of the hypusination pathway in prostate cancer progression using various models, including patient-derived tumor organoid cell lines and in vivo mouse models. We employed different omics techniques to identify the molecular mechanisms linking hypusination to the aggressiveness of prostate cancer.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313170" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>GSE306252 é€šè¿‡mRNAæµ‹åºé‰´å®šè‚ç»†èƒç™Œä¸­çš„è¯Šæ–­æ€§å¤–æ³Œä½“miRNAå’Œè‡´ç—…è°ƒæ§ç½‘ç»œ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcarcinomaã€sequencing<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xiao Jingwen ; Ma Shiyue ; Tan Qiupei ; Xiao Jianlong ; Liu Shanshan ; Shi Qingfeng ; Yang JunSeries Type : Non-coding RNA profiling by high throughput sequencingOrganism : Homo sapiensBackground/Objectives: Hepatocellular carcinoma (HCC) is the sixth most common malignancy worldwide and the third leading cause of cancer-related mortality. Prognosis is stage-dependent, but most patients are diagnosed at advanced stages when curative treatment is not feasible. Alpha-fetoprotein (AFP), the most widely used biomarker, has limited sensitivity and specificity for early detection. Serum-derived exosomal mi-croRNAs (miRNAs) are stable in circulation, tumor-specific, and actively involved in cancer biology, making them promising non-invasive biomarkers. This study aimed to identify, validate, and functionally characterize serum-derived exosomal miRNAs with diagnostic potential in HCC. Methods: Serum exosomes were isolated from 50 HCC pa-tients and 50 matched healthy controls, characterized by transmission electron micros-copy, nanoparticle tracking analysis, and CD9/CD63/CD81 flow cytometry. High-throughput small RNA sequencing of 3 HCC and 3 control samples identified dif-ferentially expressed miRNAs (DEMs). Target genes were predicted via multiple data-bases, integrated into STRING proteinâ€“protein interaction networks, and analyzed with cytoHubba. Gene Ontology (GO) and KEGG enrichment analyses were performed. Hub gene expression and survival relevance were evaluated using GEPIA2. Candidate miRNAs were validated by RT-qPCR, and diagnostic performance was assessed with receiver operating characteristic (ROC) analysis. Results: Seven DEMs were identified; FOXO1 and SRSF11 emerged as hub genes. hsa-miR-27a-3p targeted FOXO1, and hsa-miR-493-3p targeted SRSF11. RT-qPCR confirmed hsa-miR-27a-3p upregulation (P = 0.003) and hsa-miR-493-3p downregulation (P = 0.014) in HCC exosomes. ROC analysis showed high diagnostic accuracy for hsa-miR-493-3p (AUC = 0.840) and hsa-miR-27a-3p (AUC = 0.827), comparable to AFP (AUC = 0.828), with improved performance when combined. Conclusions: Serum-derived exosomal hsa-miR-27a-3p and hsa-miR-493-3p are promising non-invasive biomarkers for HCC, with diagnostic value comparable to AFP and mechanistic links to FOXO1 and SRSF11. Their integration into miRNA-based panels may improve early detection.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306252" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>GSE285347 IgAè‚¾ç—…è¡¨è§‚é—ä¼ ç”Ÿç‰©æ ‡å¿—ç‰©çš„å‘ç°ï¼šåˆ©ç”¨ATAC-Seqåˆ†æå¾ªç¯CD8+ Tç»†èƒçš„æŸ“è‰²è´¨å¼€æ”¾æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šATAC-seqã€epigenetic<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Gwanghun Kim ; Soojin Lee ; Ik Soo Kim ; Hyun Mu Shin ; Hang-Rae Kim ; Dong Ki KimSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensChromatin openess plays a critical role in understanding epigenetic regulation in disease states. Using ATAC-seq, we profiled circulating CD8+ T cells from IgA nephropathy (IgAN) patients to identify biomarkers distinguishing early and late disease stages. A total of 279 differential ATAC peaks were identified, with 122 selected as biomarkers based on fold change (&gt;2) and statistical significance (P &lt; 0.05). These biomarkers exhibited distinct chromatin accessibility patterns, highlighting differential regulatory mechanisms. Combining multiple biomarkers through weighted scoring enhanced predictive accuracy, with ROC analysis confirming their diagnostic potential. Our findings demonstrate that chromatin openness in circulating CD8+ T cells provides valuable insights into disease progression and serves as a robust platform for biomarker discovery in IgAN.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285347" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>GSE277903 Î³Î´ T ç»†èƒçš„å…ˆå¤©ç»„ç»‡å…ç–«ç›‘è§†å¯¹ T ç»†èƒå—ä½“å…·æœ‰å®æ—¶ä¾èµ–æ€§ [RNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šT cellã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Miguel Munoz-Ruiz ; Nicolas Veland ; Adrian HaydaySeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusWith clonotypic potential to engage different ligands, T cell receptor (TCR) Î³Î´ fulfils a key tenet of adaptive immunity. Nonetheless, many Î³Î´ repertoires are non-circulating, display limited diversity, and are commonly classified as innate-like, questioning any requirement for the TCR beyond the cellsâ€™ development. Addressing this long-standing issue, we now show that the steady-state phenotypes of different tissue-intrinsic Î³Î´ T cell compartments share a dependence on constitutive TCR expression. Deprived of this, cells rapidly become dysregulated, losing their capacity to respond to wide-ranging tissue insults, including imiquimod, an innate inducer of psoriasis-like pathology, u.v. irradiation, and melanoma. Thus, beyond any developmental requirements, the TCR is required in real time to regulate the cellsâ€™ innate-like tissue immunosurveillance. Biologically, this clearly distinguishes intrinsic Î³Î´ T cells from NK and other innate lymphoid cells, while clinically it stresses the importance of the TCR in delivering gd T cell-based immunotherapies.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277903" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>GSE277902 Î³Î´ T ç»†èƒçš„å…ˆå¤©ç»„ç»‡å…ç–«ç›‘è§†å¯¹ T ç»†èƒå—ä½“å…·æœ‰å®æ—¶ä¾èµ–æ€§ [ATAC-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šT cellã€ATAC-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Miguel Munoz-Ruiz ; Nicolas Veland ; Adrian HaydaySeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusWith clonotypic potential to engage different ligands, T cell receptor (TCR) Î³Î´ fulfils a key tenet of adaptive immunity. Nonetheless, many Î³Î´ repertoires are non-circulating, display limited diversity, and are commonly classified as innate-like, questioning any requirement for the TCR beyond the cellsâ€™ development. Addressing this long-standing issue, we now show that the steady-state phenotypes of different tissue-intrinsic Î³Î´ T cell compartments share a dependence on constitutive TCR expression. Deprived of this, cells rapidly become dysregulated, losing their capacity to respond to wide-ranging tissue insults, including imiquimod, an innate inducer of psoriasis-like pathology, u.v. irradiation, and melanoma. Thus, beyond any developmental requirements, the TCR is required in real time to regulate the cellsâ€™ innate-like tissue immunosurveillance. Biologically, this clearly distinguishes intrinsic Î³Î´ T cells from NK and other innate lymphoid cells, while clinically it stresses the importance of the TCR in delivering gd T cell-based immunotherapies.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277902" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 66 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>RNA-seq</td>
<td>16</td>
</tr>
<tr>
<td>cancer</td>
<td>8</td>
</tr>
<tr>
<td>T cell</td>
<td>7</td>
</tr>
<tr>
<td>tumor</td>
<td>7</td>
</tr>
<tr>
<td>genome</td>
<td>6</td>
</tr>
<tr>
<td>ATAC-seq</td>
<td>6</td>
</tr>
<tr>
<td>carcinoma</td>
<td>5</td>
</tr>
<tr>
<td>scRNA</td>
<td>5</td>
</tr>
<tr>
<td>regex:onco(logy</td>
<td>logist</td>
</tr>
<tr>
<td>sequencing</td>
<td>4</td>
</tr>
<tr>
<td>aging</td>
<td>4</td>
</tr>
<tr>
<td>ChIP-seq</td>
<td>4</td>
</tr>
<tr>
<td>immune</td>
<td>3</td>
</tr>
<tr>
<td>pathway</td>
<td>2</td>
</tr>
<tr>
<td>single-cell</td>
<td>2</td>
</tr>
<tr>
<td>transcriptome</td>
<td>2</td>
</tr>
<tr>
<td>inflammation</td>
<td>2</td>
</tr>
<tr>
<td>metabolism</td>
<td>2</td>
</tr>
<tr>
<td>leukemia</td>
<td>2</td>
</tr>
<tr>
<td>KRAS</td>
<td>2</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (66æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272538" target="_blank" rel="noopener noreferrer">GSE272538 EZH2 å’Œ E2F1 çš„æ–°å…³è”é€šè¿‡æŸ“è‰²è´¨é‡å¡‘ä¿ƒè¿›ä¹³è…ºç™Œç»†èƒå¢æ®– [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272537" target="_blank" rel="noopener noreferrer">GSE272537 EZH2 å’Œ E2F1 çš„æ–°å…³è”é€šè¿‡æŸ“è‰²è´¨é‡å¡‘ä¿ƒè¿›ä¹³è…ºç™Œç»†èƒå¢æ®– [CHIP-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272536" target="_blank" rel="noopener noreferrer">GSE272536 EZH2 å’Œ E2F1 çš„æ–°å…³è”é€šè¿‡æŸ“è‰²è´¨é‡å¡‘ä¿ƒè¿›ä¹³è…ºç™Œç»†èƒå¢æ®– [ATAC-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305891" target="_blank" rel="noopener noreferrer">GSE305891 ATF4 çš„åŸºç¡€æ°´å¹³ä¿ƒè¿› T ç»†èƒæ´»åŒ–è¯±å¯¼å¢æ®–çš„å‡†å¤‡çŠ¶æ€ [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288143" target="_blank" rel="noopener noreferrer">GSE288143 ATF4 åŸºç¡€æ°´å¹³ä¿ƒè¿› T ç»†èƒæ´»åŒ–è¯±å¯¼å¢æ®–çš„å‡†å¤‡çŠ¶æ€ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288073" target="_blank" rel="noopener noreferrer">GSE288073 ARTS é€šè¿‡ Livin-MDM2-p53 é€šè·¯è¯±å¯¼å‡‹äº¡ä¾èµ–æ€§è‡ªå™¬ï¼Œä»è€Œèµ‹äºˆä¹³è…ºç™Œç»†èƒåŒ–ç–—è€è¯æ€§ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283719" target="_blank" rel="noopener noreferrer">GSE283719 EGR1ä¾èµ–çº§è”è°ƒèŠ‚CSF1RåŸºå› åº§çš„åŸºå› ç»„ç»“æ„[Hi-C]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283718" target="_blank" rel="noopener noreferrer">GSE283718 EGR1ä¾èµ–çº§è”è°ƒèŠ‚CSF1RåŸºå› åº§çš„åŸºå› ç»„ç»“æ„[ChIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283663" target="_blank" rel="noopener noreferrer">GSE283663 EGR1ä¾èµ–çº§è”è°ƒèŠ‚CSF1RåŸºå› åº§çš„åŸºå› ç»„ç»“æ„[RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255626" target="_blank" rel="noopener noreferrer">GSE255626 åŸå‘æ€§èƒ¶è´¨æ¯ç»†èƒç˜¤æ‚£è€…ç»„ç»‡çš„ä¸‹ä¸€ä»£æµ‹åºï¼ˆæ€»RNAæµ‹åºï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE208745" target="_blank" rel="noopener noreferrer">GSE208745 è‚¿ç˜¤ç‰¹å¼‚æ€§lncRNA IGF1R-AS1åå¼è°ƒæ§ä¸è‡´ç™ŒMYCä¿¡å·ç›¸å…³çš„æŸ“è‰²è´¨ç›¸äº’ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298483" target="_blank" rel="noopener noreferrer">GSE298483 è¯±å¯¼è‚¾è„å‘è‚²ç»†èƒçŠ¶æ€ä¸é¢„åè‰¯å¥½å‹è‚¾æ¯ç»†èƒç˜¤çš„åŒ–ç–—è€è¯æ€§ç›¸å…³</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE230838" target="_blank" rel="noopener noreferrer">GSE230838 è‚è„ä¸­é¡ºå¼ç£·é…¸è½¬ç§»é…¶åŠŸèƒ½çš„ä¸§å¤±ä¿ƒè¿›äº†ä¸€ç§é«˜å¤–æ˜¾ç‡çš„è„‚è‚ªè‚ç–¾ç—…ï¼Œè¯¥ç–¾ç—…è¿…é€Ÿè½¬å˜ä¸ºè‚ç»†èƒç™Œ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE230616" target="_blank" rel="noopener noreferrer">GSE230616 è‚è„ä¸­é¡ºå¼ç£·é…¸è½¬ç§»é…¶åŠŸèƒ½çš„ä¸§å¤±ä¿ƒè¿›äº†ä¸€ç§é«˜å¤–æ˜¾ç‡çš„è„‚è‚ªè‚ç–¾ç—…ï¼Œè¯¥ç–¾ç—…è¿…é€Ÿè½¬å˜ä¸ºè‚ç»†èƒç™Œ [scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289395" target="_blank" rel="noopener noreferrer">GSE289395 pTÎ± å¢å¼º mRNA ç¿»è¯‘å¹¶å¢å¼º CAR T ç»†èƒå¯¹å®ä½“ç˜¤çš„æ ¹é™¤ä½œç”¨ [scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289390" target="_blank" rel="noopener noreferrer">GSE289390 pTÎ± å¢å¼º mRNA ç¿»è¯‘å¹¶å¢å¼º CAR T ç»†èƒå¯¹å®ä½“ç˜¤çš„æ ¹é™¤ä½œç”¨ [æ‰¹é‡ RNA æµ‹åº]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315268" target="_blank" rel="noopener noreferrer">GSE315268 é«˜èƒ½è„‰å†²ç”µå­æŸ (HEPE) è¯±å¯¼é“¾éœ‰èŒ lividans 1326 èŒæ ªåŸºå› è¡¨è¾¾çš„å…¨åŸºå› ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299892" target="_blank" rel="noopener noreferrer">GSE299892 MSC-exo å¤„ç†çš„ HUVEC çš„è½¬å½•ç»„åˆ†æç ”ç©¶</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299879" target="_blank" rel="noopener noreferrer">GSE299879 N-ä¹™é…°-L-åŠèƒ±æ°¨é…¸ä¹™é…¯ (NACET) å¯è¯±å¯¼è§†ç½‘è†œä¸­çš„è½¬å½•å› å­ NRF2ï¼Œå¹¶é˜²æ­¢è§†ç½‘è†œè€åŒ–å’Œç³–å°¿ç—…è§†ç½‘è†œç—…å˜ã€‚[IV]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299877" target="_blank" rel="noopener noreferrer">GSE299877 N-ä¹™é…°-L-åŠèƒ±æ°¨é…¸ä¹™é…¯ (NACET) å¯è¯±å¯¼è§†ç½‘è†œä¸­çš„è½¬å½•å› å­ NRF2ï¼Œå¹¶é˜²æ­¢è§†ç½‘è†œè€åŒ–å’Œç³–å°¿ç—…è§†ç½‘è†œç—…å˜ã€‚[III]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299876" target="_blank" rel="noopener noreferrer">GSE299876 N-ä¹™é…°-L-åŠèƒ±æ°¨é…¸ä¹™é…¯ (NACET) å¯è¯±å¯¼è§†ç½‘è†œä¸­çš„è½¬å½•å› å­ NRF2ï¼Œå¹¶é˜²æ­¢è§†ç½‘è†œè€åŒ–å’Œç³–å°¿ç—…è§†ç½‘è†œç—…å˜ã€‚[II]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299875" target="_blank" rel="noopener noreferrer">GSE299875 N-ä¹™é…°-L-åŠèƒ±æ°¨é…¸ä¹™é…¯ (NACET) å¯è¯±å¯¼è§†ç½‘è†œä¸­è½¬å½•å› å­ NRF2 çš„è¡¨è¾¾ï¼Œå¹¶é¢„é˜²è§†ç½‘è†œè¡°è€å’Œç³–å°¿ç—…è§†ç½‘è†œç—…å˜ã€‚[I]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297705" target="_blank" rel="noopener noreferrer">GSE297705 ç”²åŸºçº¢æ†èŒ AM1 é‡ç”Ÿå‹å’Œç”²é†‡é€‚åº”èŒæ ªçš„ RNA-seq æ•°æ® [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294020" target="_blank" rel="noopener noreferrer">GSE294020 U2AF2 ç¼ºé™·å¯¹åµå·¢ç™Œç»†èƒåŸºå› è¡¨è¾¾çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293681" target="_blank" rel="noopener noreferrer">GSE293681 é¶å‘é•¿é“¾éç¼–ç RNA lnc-Megaclusterå¯¹è‚¥èƒ–ç—‡çš„ä»£è°¢æœ‰ç›Šä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290701" target="_blank" rel="noopener noreferrer">GSE290701 æŠ—æ°§åŒ–çº³ç±³æŠ€æœ¯ä»‹å¯¼çš„å¤ªç©ºç¥ç»å…ƒæŸä¼¤é˜²æŠ¤ï¼ˆPROMETEOï¼ŒæŠ—æ°§åŒ–ä¿æŠ¤ï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289379" target="_blank" rel="noopener noreferrer">GSE289379 DNAç”²åŸºåŒ–å¯é¢„æµ‹å›Šæ€§çº¤ç»´åŒ–æ‚£è€…ç—°æ¶²æ ·æœ¬ä¸­çš„è‚ºåŠŸèƒ½å’Œè‚ºéƒ¨æ€¥æ€§åŠ é‡æƒ…å†µ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285335" target="_blank" rel="noopener noreferrer">GSE285335 IgANæ‚£è€…å¤–å‘¨è¡€å•æ ¸ç»†èƒçš„å•ç»†èƒè½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285114" target="_blank" rel="noopener noreferrer">GSE285114 LOXL2 ç¼ºå¤±åœ¨åˆ›ä¼¤åæŸä¼¤ä¸­ä¼šæ‰°ä¹±è†å…³èŠ‚ç¨³æ€ï¼Œå¹¶ä¿ƒè¿›ç–¼ç—›æ•æ„Ÿæ€§ã€ç‚ç—‡å’Œéª¨å…³èŠ‚ç‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE262416" target="_blank" rel="noopener noreferrer">GSE262416 ç¾ä¸¸é—´è´¨ç»¼åˆå›¾è°±æ­ç¤º Cd34+/Sox4+ é—´å……è´¨ç»†èƒæ˜¯æ½œåœ¨çš„ Leydig ç»†èƒç¥–ç»†èƒ [scRNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE247323" target="_blank" rel="noopener noreferrer">GSE247323 æ¯ä½“è¡¥å……å²å“šå¯é€šè¿‡æ”¹å˜è‚ é“èŒç¾¤å’ŒèŠ³çƒƒå—ä½“ä»‹å¯¼çš„ç¥ç»é…°èƒºä»£è°¢æ¥ä¿æŠ¤åä»£å…å—éé…’ç²¾æ€§è„‚è‚ªæ€§è‚ç—… (NAFLD) çš„ä¾µå®³</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316529" target="_blank" rel="noopener noreferrer">GSE316529 JAK1 åŠŸèƒ½ä¸§å¤±å¯¼è‡´ G2/M ç»†èƒå‘¨æœŸç¼ºé™·ï¼Œæ˜“å— KIF18A æŠ‘åˆ¶çš„å½±å“ [Detroit562 RNAseq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312457" target="_blank" rel="noopener noreferrer">GSE312457 RNA-Seq æ•°æ®æ¥è‡ª Pdgfra-Cre ä»‹å¯¼çš„ Esr1 æ¡ä»¶æ€§æ•²é™¤å°é¼ çš„è¾“åµç®¡åŸºè´¨ç»†èƒ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310469" target="_blank" rel="noopener noreferrer">GSE310469 RNA-seq æ•°æ®ç”¨äºç ”ç©¶è¾“åµç®¡é—´è´¨ç»†èƒå’Œ/æˆ–é›Œæ¿€ç´ æ²»ç–—å¯¹è¾“åµç®¡ä¸Šçš®ç»†èƒçš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307602" target="_blank" rel="noopener noreferrer">GSE307602 DKK3 æœ€åˆé€šè¿‡ MEK-Fos ä¿¡å·é€šè·¯ç»´æŒè…ºæ³¡å®Œæ•´æ€§ï¼Œä½†éšååœ¨èƒ°è…ºå¯¼ç®¡è…ºç™Œä¸­è½¬å˜ä¸ºè‡´ç™Œä½œç”¨ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306878" target="_blank" rel="noopener noreferrer">GSE306878 è‚¿ç˜¤æŠ‘åˆ¶å› å­RESTå¯¹é›Œæ¿€ç´ å—ä½“ï¼ˆESR1ï¼‰è¡¨è¾¾å’Œå­å®«è‚Œç˜¤ç—…ç†ç”Ÿç†å­¦çš„è°ƒæ§ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305975" target="_blank" rel="noopener noreferrer">GSE305975 ATF4 çš„åŸºç¡€æ°´å¹³ä¿ƒè¿› T ç»†èƒæ´»åŒ–è¯±å¯¼å¢æ®–çš„å‡†å¤‡çŠ¶æ€</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305890" target="_blank" rel="noopener noreferrer">GSE305890 ATF4 çš„åŸºç¡€æ°´å¹³ä¿ƒè¿› T ç»†èƒæ´»åŒ–è¯±å¯¼å¢æ®–çš„å‡†å¤‡çŠ¶æ€ [CUT&amp;Run]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303595" target="_blank" rel="noopener noreferrer">GSE303595 Leo1 ç¼ºå¤±æ­ç¤º Set1 ä¾èµ–æ€§è½¬å½•æ¿€æ´» [ChIP-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298999" target="_blank" rel="noopener noreferrer">GSE298999 ANCAç›¸å…³æ€§è¡€ç®¡ç‚ä¸­å…ç–«ç›¸å…³åŸºå› çš„è‚¾è„è½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298852" target="_blank" rel="noopener noreferrer">GSE298852 NSMF å‡è½»è¿‡åº¦å¤åˆ¶å‹åŠ›ä»¥ä¿ƒè¿›ç»“ç›´è‚ ç™Œè¿›å±•</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298293" target="_blank" rel="noopener noreferrer">èƒ¸è…º iNKT ç»†èƒçš„ GSE298293 å•ç»†èƒ RNA æµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298292" target="_blank" rel="noopener noreferrer">GSE298292 å…¨èƒ¸è…ºç»†èƒå’Œçº¯åŒ–çš„ CD4+CD8+TCRlow DP èƒ¸è…ºç»†èƒçš„ RNA æµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298291" target="_blank" rel="noopener noreferrer">GSE298291 DPèƒ¸è…ºç»†èƒçš„ATAC-seq</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297499" target="_blank" rel="noopener noreferrer">GSE297499ï¼šæ‚£æœ‰ç¥ç»ç²¾ç¥æ€§é•¿æ–°å† çš„å¥³æ€§è„‘è„Šæ¶²å…ç–«ç»†èƒæ”¹å˜</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297480" target="_blank" rel="noopener noreferrer">GSE297480 BRG1/BRM æŠ‘åˆ¶å‰‚ä¸ BET æŠ‘åˆ¶å‰‚æˆ–åœ°è¥¿ä»–æ»¨è”åˆæ²»ç–—é«˜å± MECOM é‡æ’ AML çš„é«˜æ•ˆç–—æ•ˆ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297477" target="_blank" rel="noopener noreferrer">GSE297477 BRG1/BRM æŠ‘åˆ¶å‰‚ä¸ BET æŠ‘åˆ¶å‰‚æˆ–åœ°è¥¿ä»–æ»¨è”åˆæ²»ç–—é«˜å± MECOM é‡æ’ AML çš„é«˜æ•ˆç–—æ•ˆ [ChIP-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297475" target="_blank" rel="noopener noreferrer">GSE297475 BRG1/BRM æŠ‘åˆ¶å‰‚ä¸ BET æŠ‘åˆ¶å‰‚æˆ–åœ°è¥¿ä»–æ»¨è”åˆæ²»ç–—é«˜å± MECOM é‡æ’ AML çš„é«˜æ•ˆç–—æ•ˆ [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296003" target="_blank" rel="noopener noreferrer">GSE296003 ç»„è›‹ç™½3èµ–æ°¨é…¸56ä¹™é…°åŒ–ï¼ˆH3K56acï¼‰è°ƒæ§æŸ“è‰²ä½“å¤–DNAï¼ˆecDNAï¼‰æ¢çº½çš„ç”Ÿç‰©åˆæˆ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293519" target="_blank" rel="noopener noreferrer">GSE293519 é›„æ¿€ç´ ä¿¡å·åœ¨ 2 å‹å›ºæœ‰æ·‹å·´ç»†èƒä¸­é©±åŠ¨å¹½é—¨èºæ†èŒæ„ŸæŸ“å¼•èµ·çš„èƒƒç‚ç—‡å’Œèç¼©çš„æ€§åˆ«å·®å¼‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283672" target="_blank" rel="noopener noreferrer">GSE283672 EGR1ä¾èµ–çº§è”è°ƒèŠ‚CSF1RåŸºå› åº§çš„åŸºå› ç»„ç»“æ„[CUT&amp;Run]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283670" target="_blank" rel="noopener noreferrer">GSE283670 EGR1ä¾èµ–çº§è”è°ƒèŠ‚CSF1RåŸºå› åº§çš„åŸºå› ç»„ç»“æ„[Capture-C]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283238" target="_blank" rel="noopener noreferrer">GSE283238 DKK3 æœ€åˆé€šè¿‡ MEK-Fos ä¿¡å·ä¼ å¯¼æ¥ç»´æŒè…ºæ³¡å®Œæ•´æ€§ï¼Œä½†åæ¥åœ¨ PDAC ä¸­è½¬å˜ä¸ºè‡´ç™Œä½œç”¨ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279659" target="_blank" rel="noopener noreferrer">GSE279659 CD40Lé¶å‘å·¥ç¨‹åŒ–è°ƒèŠ‚æ€§Tç»†èƒä½œä¸ºä¸€ç§æ²»ç–—Tç»†èƒä»‹å¯¼çš„ç‚ç—‡æ€§ç–¾ç—…çš„æ–°å‹ç»†èƒç–—æ³•</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315410" target="_blank" rel="noopener noreferrer">GSE315410 è‚è„ä¸­é¡ºå¼ç£·é…¸è½¬ç§»é…¶åŠŸèƒ½çš„ä¸§å¤±ä¿ƒè¿›äº†ä¸€ç§é«˜å¤–æ˜¾ç‡çš„è„‚è‚ªè‚ç–¾ç—…ï¼Œè¯¥ç–¾ç—…è¿…é€Ÿè½¬å˜ä¸ºè‚ç»†èƒç™Œ [RNAseq_ChowDiet_NgBR_Liver]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288778" target="_blank" rel="noopener noreferrer">GSE288778 MYRF æ§åˆ¶é—´çš®ç»†èƒåˆ†åŒ–ã€ä¿¡å·ä¼ å¯¼å’Œå¯å¡‘æ€§ [scRNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288777" target="_blank" rel="noopener noreferrer">GSE288777 MYRF æ§åˆ¶é—´çš®ç»†èƒåˆ†åŒ–ã€ä¿¡å·ä¼ å¯¼å’Œå¯å¡‘æ€§ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287422" target="_blank" rel="noopener noreferrer">GSE287422 MYCN å’Œ ALK å…±è¡¨è¾¾è¯±å¯¼äºº iPS ç»†èƒè¡ç”Ÿçš„é¢…ç¥ç»åµ´ç»†èƒå‘ç”Ÿç¥ç»æ¯ç»†èƒç˜¤æ ·è‚¿ç˜¤ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE230972" target="_blank" rel="noopener noreferrer">GSE230972 ç ”ç©¶å‘ç°ï¼Œè‚è„ä¸­é¡ºå¼ç£·é…¸è½¬ç§»é…¶ï¼ˆcisPTaseï¼‰åŠŸèƒ½çš„ä¸§å¤±ä¼šä¿ƒè¿›ä¸€ç§é«˜å¤–æ˜¾ç‡çš„è„‚è‚ªè‚ç–¾ç—…çš„å‘ç”Ÿï¼Œè¯¥ç–¾ç—…ä¼šè¿…é€Ÿå‘å±•ä¸ºè‚ç»†èƒç™Œã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316672" target="_blank" rel="noopener noreferrer">GSE316672 åˆ©ç”¨ GeoMx DSP å¯¹ç»†æ”¯æ°”ç®¡è¿›è¡Œç©ºé—´è½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316596" target="_blank" rel="noopener noreferrer">åˆ©ç”¨å•å…‹ç½—ä»–æ—ï¼ˆMCTï¼‰è¯±å¯¼çš„è‚ºåŠ¨è„‰é«˜å‹ï¼ˆPHï¼‰å¤§é¼ æ¨¡å‹ï¼Œé€šè¿‡RNAæµ‹åºåˆ†æé‰´å®šäº†å³å¿ƒæˆ¿ç»„ç»‡ä¸­çš„åŸºå› è¡¨è¾¾å˜åŒ–ï¼ˆGSE316596ï¼‰ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308540" target="_blank" rel="noopener noreferrer">GSE308540 RORÎ³é€šè¿‡ä¸Šè°ƒNGFä¿¡å·é€šè·¯é©±åŠ¨éå°ç»†èƒè‚ºç™Œè¿›å±•</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304796" target="_blank" rel="noopener noreferrer">GSE304796 pTÎ± å¢å¼º mRNA ç¿»è¯‘å¹¶å¢å¼º CAR T ç»†èƒå¯¹å®ä½“ç˜¤çš„æ ¹é™¤ä½œç”¨ [Ribo-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304795" target="_blank" rel="noopener noreferrer">GSE304795 pTÎ± å¢å¼º mRNA ç¿»è¯‘å¹¶å¢å¼º CAR T ç»†èƒå¯¹å®ä½“ç˜¤çš„æ ¹é™¤ä½œç”¨ [eCLIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302228" target="_blank" rel="noopener noreferrer">GSE302228 ä¸‹ä¸€ä»£æµ‹åºæœ‰åŠ©äºå¯¹ç»åŒ–åˆç‰© 20 å¤„ç†æˆ–æœªå¤„ç†çš„ç™½è‰²å¿µç èŒ SC5314 è¿›è¡Œè½¬å½•è°±å®šé‡åˆ†æã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248722" target="_blank" rel="noopener noreferrer">GSE248722 Cyfip2 æ•²é™¤å°é¼ å‰è„‘å•ç»†èƒè½¬å½•ç»„åˆ†æ</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-01-22 21:43</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>